PMGC Holdings Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
1.070
-0.020 (-1.83%)
At close: Jul 17, 2026, 4:00 PM EDT
1.070
0.00 (0.02%)
After-hours: Jul 17, 2026, 7:58 PM EDT
PMGC Holdings Employees
As of December 31, 2025, PMGC Holdings had 34 total employees, including 32 full-time and 2 part-time employees. The number of employees increased by 31 or 1,033.33% compared to the previous year.
Employees
34
Change (1Y)
31
Growth (1Y)
1,033.33%
Revenue / Employee
$37,414
Profits / Employee
-$326,665
Market Cap
4.86M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 34 | 31 | 1,033.33% | 32 | 2 |
| Dec 31, 2024 | 3 | -15 | -83.33% | 2 | 1 |
| Dec 31, 2023 | 18 | 4 | 28.57% | 18 | 0 |
| Jun 30, 2023 | 16 | - | - | 16 | 0 |
| Mar 31, 2023 | 14 | - | - | 14 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Cardio Diagnostics Holdings | 17 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| Dermata Therapeutics | 9 |
| Alzamend Neuro | 6 |
| Enveric Biosciences | 6 |
| Mustang Bio | 4 |
ELAB News
- 5 days ago - NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications - GlobeNewsWire
- 8 days ago - NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression - GlobeNewsWire
- 12 days ago - PMGC merges AGA Precision Systems into A&B Aerospace - TheFly
- 12 days ago - PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace - GlobeNewsWire
- 17 days ago - Wall Street is Watching These Biotechs - GlobeNewsWire
- 17 days ago - NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences - GlobeNewsWire
- 4 weeks ago - PMGC subsidiary files two new U.S. patent applications on EL-22, EL-32 - TheFly
- 4 weeks ago - NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets - GlobeNewsWire